Ligand ID: ROF Drugbank ID: DB01656(Roflumilast) Indication:Roflumilast is indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. Roflumilast is not a bronchodilator and is not indicated for the relief of acute bronchospasm. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 4 / 5 | ASN B 151THR B 111GLN B 127PHE B 8 | 1.74A | 21.43 | None | ||
![]() | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 1uj1 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS A 41ASN A 28TYR A 118SER B 1PHE A 140 | 1.67A | 21.23 | None | ||
![]() | 3G4L_C_ROFC903_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 1uk3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASP A 229LEU A 232ASN A 231PRO A 241THR A 243 | 1.68A | 21.23 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 1uk4 | 3C-LIKE PROTEINASE5-MER PEPTIDE OFINHIBITOR (SARSr-CoV) | 4 / 5 | ASN H 1THR H 3MET B 165GLN B 189 | 1.62A | 3.16 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 1uk4 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.63A | 21.84 | None | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 1uk4 | 3C-LIKE PROTEINASE5-MER PEPTIDE OFINHIBITOR (SARSr-CoV) | 3 / 3 | SER B 1GLN G 5PHE A 140 | 1.08A | 21.23 | NoneATO A1006 (-4.6A)None | ||
![]() | 1XMU_A_ROFA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 1uk4 | 3C-LIKE PROTEINASE5-MER PEPTIDE OFINHIBITOR (SARSr-CoV) | 4 / 5 | ASN H 1THR H 3MET B 165GLN B 189 | 1.61A | 3.16 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 1wyy | E2 GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | ASP B1180LEU B1178GLN A 939 | 1.33A | 19.68 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 1x7q | HLA, A-11 (Homosapiens) | 3 / 3 | ASP A 74LEU A 78GLN A 87 | 1.20A | 19.95 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 1z1i | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | ASP A 33LEU A 32GLN A 83 | 0.98A | 21.23 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B1006ASP B1295TYR B1154ILE B1152SER A 121 | 1.70A | 20.69 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN B1151THR B1111GLN B1127PHE B1008 | 1.66A | 21.84 | None | ||
![]() | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS A 41ASN A 28TYR A 118SER B1001PHE A 140 | 1.76A | 21.23 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS B1041MET B1162THR B1026SER B1121GLN B1019 | 1.72A | 21.23 | None | ||
![]() | 1XMU_B_ROFB102_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B1006ASP B1295TYR B1154ILE B1152SER A 121 | 1.62A | 21.84 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 3 / 3 | ASP G 57LEU G 14GLN D 36 | 1.32A | 18.01 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAIN (SARSr-CoV) | 5 / 12 | ASP H 168THR H 192ILE H 190MET H 134GLN H 163 | 1.78A | 18.01 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ahm | REPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 3 / 3 | ASP C 43LEU C 46GLN B 24 | 0.95A | 12.89 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 2alv | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.74A | 21.23 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2bx3 | MAIN PROTEINASE (SARS-COVSin2774) | 5 / 12 | HIS A 41MET A 162THR A 26SER A 121GLN A 19 | 1.68A | 21.23 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2c3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | ASN A 133MET A 165PHE A 185 | 1.41A | 21.23 | None | ||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 2cjr | NUCLEOCAPSID PROTEIN (SARS-COVTW1) | 5 / 12 | TYR A 334ILE B 321PHE A 287SER B 313PHE B 315 | 1.48A | 15.64 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.62A | 22.19 | None | ||
![]() | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2dd8 | IGG HEAVY CHAIN (Homosapiens) | 5 / 12 | ASP H 95PRO H 52THR H 70ILE H 69SER H 21 | 1.65A | 19.37 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2dd8 | IGG HEAVY CHAIN (Homosapiens) | 5 / 12 | ASP H 95PRO H 52THR H 70ILE H 69SER H 21 | 1.63A | 19.37 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2dd8 | IGG HEAVY CHAIN (Homosapiens) | 5 / 12 | ASP H 95PRO H 52THR H 70ILE H 69SER H 21 | 1.66A | 18.83 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | ASN B 157MET B 85PHE B 80 | 1.68A | 23.99 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2fyg | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | ASP A 91LEU A 92GLN A 98 | 0.92A | 16.10 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 3 / 3 | ASP Q 91LEU Q 92GLN Q 98 | 0.85A | 15.28 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ghw | ANTI-SCFV ANTIBODY,80R (Homosapiens) | 3 / 3 | ASP B 105LEU B 104GLN B 6 | 1.29A | 19.42 | None | ||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 2gib | NUCLEOCAPSID PROTEIN (SARSr-CoV) | 5 / 12 | TYR A 334ILE B 321PHE A 287SER B 313PHE B 315 | 1.72A | 13.01 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 2gtb | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.74A | 21.84 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2kys | NSP7 (SARSr-CoV) | 3 / 3 | ASP A 40LEU A 43GLN A 85 | 1.35A | 11.85 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 3 / 3 | ASP A 212LEU A 216GLN A 259 | 1.13A | 22.00 | None | ||
![]() | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | HIS B 234MET B 330ASN D 277TYR D 278ILE D 269 | 1.04A | 22.00 | None | ||
![]() | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | TYR D 193LEU D 331THR D 321ILE D 322PHE D 329 | 1.77A | 20.37 | None | ||
![]() | 3G4L_C_ROFC903_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 6 / 12 | HIS B 234MET B 330ASP B 239ASN D 277TYR D 278ILE D 269 | 1.37A | 22.00 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | HIS B 234MET B 330ASP B 239TYR D 278ILE D 269 | 1.38A | 20.37 | None | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 3 / 3 | SER A 241GLN A 244PHE A 329 | 1.33A | 22.00 | None | ||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | ASP B 212TYR B 237ILE B 252PHE B 203SER B 258 | 1.32A | 20.33 | None | ||
![]() | 3G4L_B_ROFB902_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | TYR D 193LEU D 331THR D 321ILE D 322PHE D 329 | 1.77A | 22.00 | None | ||
![]() | 1XMU_B_ROFB102_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | HIS B 234MET B 330ASP B 239TYR D 278ILE D 269 | 1.30A | 20.33 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 4 / 5 | ASN B 151THR B 111GLN B 127PHE B 8 | 1.73A | 22.11 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2qcy | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS A 41MET A 162THR A 26SER A 121GLN A 19 | 1.79A | 21.23 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 2qiq | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.73A | 21.23 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2xyq | NSP10 (SARSr-CoV) | 3 / 3 | ASP B 91LEU B 92GLN B 98 | 0.95A | 13.58 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2xyq | NSP10PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | ASP A 106PRO B 59THR B 56ILE B 55GLN B 98 | 1.53A | 20.05 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2xyr | NSP10PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | ASP A 106PRO B 59THR B 56ILE B 55GLN B 98 | 1.50A | 20.68 | None | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | MET A 42ASN A 29GLN A 28 | 1.21A | 22.95 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3atw | 3C-LIKE PROTEINASEPEPTIDEACE-THR-VAL-ALC-HIS-H (SARSr-CoV) | 4 / 5 | THR D 2MET B 165GLN B 192PHE B 185 | 1.44A | 6.90 | ACE D 1 ( 4.2A)ALC D 4 (-4.1A)NoneNone | ||
![]() | 1XMU_A_ROFA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3atw | 3C-LIKE PROTEINASEPEPTIDEACE-THR-VAL-ALC-HIS-H (SARSr-CoV) | 4 / 5 | MET A 130THR C 2MET A 165GLN A 192 | 1.78A | 21.52 | NoneACE C 1 ( 4.3A)ALC C 4 (-4.0A)None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3aw1 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.68A | 21.52 | None | ||
![]() | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3aw1 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS A 41ASN A 28TYR A 118SER B 1PHE A 140 | 1.69A | 21.23 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3bgf | F26G19 FAB (Musmusculus) | 3 / 3 | ASP L 82LEU L 104GLN L 6 | 1.06A | 19.42 | None | ||
![]() | 1XMU_A_ROFA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 5 | ASN B 49THR B 52MET B 332GLN B 340 | 1.77A | 19.83 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | TYR A 381HIS A 401MET A 408LEU A 554MET A 383 | 1.74A | 21.28 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.60A | 20.99 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | ASP A 33LEU A 32GLN A 83 | 1.05A | 21.43 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN B 151THR B 111GLN B 127PHE B 8 | 1.73A | 21.23 | None | ||
![]() | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS A 41ASN A 28TYR A 118SER B 1PHE A 140 | 1.67A | 21.23 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | ASN B 133MET B 165PHE B 185 | 1.38A | 21.23 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3f9e | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | ASN A 142MET A 6PHE A 140 | 1.53A | 21.23 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3f9f | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS A 163MET A 17LEU A 115SER A 158PHE A 150 | 1.79A | 20.16 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.66A | 21.23 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS A 163MET A 17LEU A 115SER A 158PHE A 150 | 1.80A | 20.27 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.70A | 20.89 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.73A | 20.99 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS A 41MET A 162THR A 26SER A 121GLN A 19 | 1.64A | 21.85 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | ASP A 33LEU A 32GLN A 83 | 1.07A | 21.85 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3i6k | HLA, A-2 (Homosapiens) | 3 / 3 | ASP E 129LEU E 130GLN E 115 | 1.32A | 19.95 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3i6l | HLA, A-24 (Homosapiens) | 3 / 3 | ASP D 74LEU D 78GLN D 87 | 1.08A | 17.99 | None | ||
![]() | 3G4L_B_ROFB902_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3i6l | HLA, A-24NUCLEOPROTEINPEPTIDE (Homosapiens;SARSr-CoV) | 5 / 12 | MET D 97ASP D 74THR D 64MET D 45PHE F 2 | 1.73A | 17.99 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.72A | 21.84 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | ASP A 33LEU A 32GLN A 83 | 1.10A | 20.65 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | ASN A 133MET A 165PHE A 185 | 1.35A | 20.65 | None | ||
![]() | 1XMU_B_ROFB102_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3r24 | 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | TYR A 181HIS A 225TRP A 190PHE A 150SER A 129 | 1.70A | 23.27 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3r24 | NSP10 AND NSP11 (SARSr-CoV) | 3 / 3 | ASP B 91LEU B 92GLN B 98 | 1.14A | 15.10 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3r24 | 2'-O-METHYLTRANSFERASENSP10 AND NSP11 (SARSr-CoV) | 5 / 12 | ASP A 106PRO B 59THR B 56ILE B 55GLN B 98 | 1.51A | 22.41 | None | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3sci | ACE2 (Homosapiens) | 3 / 3 | MET B 249ASN B 599GLN B 598 | 1.65A | 19.87 | None | ||
![]() | 1XMU_A_ROFA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3scj | ACE2 (Homosapiens) | 4 / 5 | ASN A 49THR A 52MET A 332GLN A 340 | 1.65A | 20.00 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3scj | ACE2 (Homosapiens) | 5 / 12 | TYR A 381HIS A 401MET A 408LEU A 554MET A 383 | 1.70A | 22.38 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3scj | ACE2 (Homosapiens) | 4 / 5 | ASN A 49THR A 52MET A 332GLN A 340 | 1.66A | 20.00 | None | ||
![]() | 3G4L_B_ROFB902_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | TYR B 127LEU B 456PRO B 500TRP B 168MET B 123 | 1.76A | 22.22 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | TYR A 381HIS A 401MET A 408LEU A 554MET A 383 | 1.76A | 22.22 | None | ||
![]() | 1XMU_A_ROFA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 5 | ASN B 49THR B 52MET B 332GLN B 340 | 1.78A | 19.83 | None | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 3snb | 3C-LIKE PROTEINASEPEPTIDE ALDEHYDEINHIBITOR AC-DSFDQ-H (SARSr-CoV) | 3 / 3 | SER H 2GLN A 189PHE H 3 | 1.14A | 1.50 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN B 151THR B 111GLN B 127PHE B 8 | 1.72A | 21.20 | None | ||
![]() | 3G4L_C_ROFC903_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASP A 229LEU A 232ASN A 231PRO A 241THR A 243 | 1.72A | 22.89 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 4ovz | PAPAIN-LIKEPROTEINASE (SARS-COVUrbani) | 3 / 3 | ASN B 157MET B 85PHE B 80 | 1.71A | 24.05 | None | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 4ow0 | PAPAIN-LIKE PROTEASE (SARS-COVUrbani) | 3 / 3 | MET A 170ASN A 178GLN A 134 | 1.49A | 22.49 | NoneDMS A 905 (-3.1A)None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 4tww | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | ASP A 33LEU A 32GLN A 83 | 1.15A | 21.23 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.72A | 21.20 | None | ||
![]() | 3G4L_C_ROFC903_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5c5o | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASP B 229LEU B 232ASN B 231PRO B 241THR B 243 | 1.70A | 21.23 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5c8s | NSP10 (SARSr-CoV) | 3 / 3 | ASP C 91LEU C 92GLN C 98 | 1.11A | 14.88 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | ASN D 499MET D 315PHE D 444 | 1.55A | 21.37 | None | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | MET B 241ASN B 63GLN B 65 | 1.75A | 20.04 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | ASP B 331LEU B 329GLN D 493 | 1.08A | 21.37 | None | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | MET D 241ASN D 63GLN D 65 | 1.67A | 20.18 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | ASP B 331LEU B 329GLN D 493 | 1.02A | 21.54 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | ASN D 499MET D 315PHE D 444 | 1.48A | 21.54 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | ASN D 157MET D 85PHE D 80 | 1.65A | 25.00 | None | ||
![]() | 1XMU_B_ROFB102_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | MET D 195LEU D 185ILE D 87PHE D 111SER D 271 | 1.76A | 21.00 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 3 / 3 | ASN B 499MET B 315PHE B 444 | 1.58A | 21.37 | None | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 3 / 3 | MET B 241ASN B 63GLN B 65 | 1.67A | 20.94 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.78A | 18.38 | NoneNoneDMS A 402 (-3.4A)DMS A 402 (-3.8A) | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5tl7 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | ASN D 157MET D 85PHE D 80 | 1.65A | 24.05 | None | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5tl7 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | MET D 170ASN D 178GLN D 134 | 1.42A | 22.75 | None | ||
![]() | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5x4r | S PROTEIN (MERS-CoV) | 5 / 12 | ASP A 338LEU A 321TYR A 71ILE A 56MET A 278 | 1.80A | 19.69 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 3 / 3 | ASN B1101MET C 882PHE B1077 | 1.52A | 15.44 | None | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 3 / 3 | SER B 701GLN B 908PHE B 700 | 1.28A | 15.44 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 5 | ASN B 269THR B 271GLN A 546PHE B 47 | 1.60A | 15.14 | NAG B1309 (-1.8A)NoneNoneNone | ||
![]() | 3G4L_C_ROFC903_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | LEU C 283ASN C 281PRO C 282TYR C 622THR C 624 | 1.68A | 15.44 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | TYR B 266ASP B 44THR B 271ILE B 272GLN A 546 | 1.68A | 15.44 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | TYR B 598PRO C 844THR B 631ILE B 652MET B 679 | 1.80A | 14.73 | None | ||
![]() | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | TYR B 598PRO C 844THR B 631ILE B 652MET B 679 | 1.80A | 14.73 | None | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 3 / 3 | MET B 884ASN B 910GLN B 786 | 1.61A | 14.73 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5x5c | S PROTEIN (MERS-CoV) | 3 / 3 | ASP B 422LEU B 481GLN B 471 | 1.01A | 15.12 | None | ||
![]() | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5x5f | S PROTEIN (MERS-CoV) | 5 / 12 | ASP A 338LEU A 321TYR A 71ILE A 56MET A 278 | 1.72A | 14.23 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | ASN A1107MET C 882PHE A1071 | 1.56A | 15.79 | ASN A1107 ( 0.6A)MET C 882 ( 0.0A)PHE A1071 ( 1.3A) | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | SER A 985GLN A 947PHE C 741 | 1.56A | 15.79 | SER A 985 ( 0.0A)GLN A 947 ( 0.6A)PHE C 741 ( 1.3A) | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 5y3e | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 3 / 3 | MET A 170ASN A 178GLN A 134 | 1.44A | 22.37 | None | ||
![]() | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | TYR C 771LEU C 876THR C 865ILE A 687SER A 690 | 1.74A | 14.88 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | TYR C1049MET C 884LEU C 898ILE C 702GLN C 908 | 1.76A | 15.79 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | ASN C 783MET C1032PHE C 782 | 1.34A | 15.79 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | ASP C 454LEU C 448GLN C 396 | 1.29A | 15.79 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 3 / 3 | ASN B 907MET B1032PHE B 782 | 1.55A | 16.00 | None | ||
![]() | 3G4L_B_ROFB902_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | TYR B 266ASP B 44THR B 271ILE B 272PHE A 548 | 1.74A | 16.00 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | TYR B 266ASP B 44THR B 271ILE B 272PHE A 548 | 1.71A | 14.15 | None | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 3 / 3 | SER A 740GLN A 744PHE A 741 | 1.76A | 16.00 | None | ||
![]() | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | TYR B 266ASP B 44THR B 271ILE B 272PHE A 548 | 1.73A | 14.15 | None | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 3 / 3 | MET B 882ASN A1090GLN A1088 | 1.50A | 14.36 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 5 | ASN A 269THR A 271GLN C 546PHE A 47 | 1.65A | 15.76 | NAG A1302 (-1.8A)NoneNoneNone | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 3 / 3 | SER B 740GLN A 947PHE B 741 | 0.98A | 15.71 | None | ||
![]() | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | TYR C 266ASP C 44THR C 271ILE C 272PHE B 548 | 1.79A | 14.36 | None | ||
![]() | 1XMU_A_ROFA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 5 | MET B 263ASN B 942THR B 943GLN C 744 | 1.35A | 15.76 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | TYR C 266ASP C 44THR C 271ILE C 272PHE B 548 | 1.78A | 14.36 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 3 / 3 | ASP C 757LEU C 846GLN B 632 | 1.25A | 15.71 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU C 235THR C 150ILE C 117SER C 120GLN C 147 | 1.63A | 15.71 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 3 / 3 | ASN B 783MET B 884PHE B 909 | 1.25A | 15.71 | NAG B1315 (-1.8A)NoneNone | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6cs2 | ACE2 (Homosapiens) | 4 / 5 | ASN D 49THR D 52MET D 332GLN D 340 | 1.61A | 20.00 | None | ||
![]() | 1XMU_A_ROFA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6cs2 | ACE2 (Homosapiens) | 4 / 5 | ASN D 49THR D 52MET D 332GLN D 340 | 1.59A | 20.00 | None | ||
![]() | 3G4L_C_ROFC903_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | HIS B 554ASN B 177PRO B 175TYR B 180THR B 410 | 1.69A | 19.83 | None | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6jyt | HELICASE (SARSr-CoV) | 3 / 3 | SER B 555GLN B 548PHE B 561 | 1.76A | 19.83 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.78A | 21.71 | NoneNoneDMS A 402 (-3.4A)DMS A 402 (-3.8A) | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | ASP A 216LEU A 282GLN A 299 | 1.79A | 21.67 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6lzg | ACE2 (Homosapiens) | 5 / 12 | TYR A 381HIS A 401MET A 408LEU A 554MET A 383 | 1.70A | 21.44 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 3 / 3 | ASP A 216LEU A 282GLN A 299 | 1.79A | 21.53 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.76A | 21.67 | NoneNoneDMS A 404 (-3.3A)DMS A 404 (-3.8A) | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6m18 | ACE2 (Homosapiens) | 4 / 5 | ASN D 49THR D 52MET D 332GLN D 340 | 1.64A | 19.08 | NoneNoneNoneNAG D 901 (-4.2A) | ||
![]() | 1XMU_A_ROFA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6m18 | ACE2 (Homosapiens) | 4 / 5 | ASN D 49THR D 52MET D 332GLN D 340 | 1.64A | 19.08 | NoneNoneNoneNAG D 901 (-4.2A) | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 3 / 3 | SER C 338GLN C 357PHE C 337 | 0.96A | 19.00 | None | ||
![]() | 1XOQ_A_ROFA502_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6m1d | ACE2 (Homosapiens) | 3 / 3 | ASN D 103TRP D 69GLN D 101 | 1.64A | 17.95 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6m1d | ACE2 (Homosapiens) | 3 / 3 | ASP B 350LEU B 351GLN B 42 | 1.34A | 18.12 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 5 | ASN C 151THR C 111GLN C 127PHE C 8 | 1.80A | 21.84 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 5 | ASN D 151THR D 111GLN D 127PHE D 8 | 1.78A | 21.84 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.80A | 21.84 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 5 | ASN B 151THR B 111GLN B 127PHE B 8 | 1.79A | 21.84 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | ASP D 216LEU D 282GLN D 299 | 1.78A | 21.43 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.74A | 21.84 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | HIS C 60LEU C 57THR B 166ILE A 95GLN B 71 | 1.47A | 16.08 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | HIS A 381MET B 87THR A 540ILE A 539SER A 501 | 1.63A | 17.87 | None | ||
![]() | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | MET B 87THR A 540ILE A 539SER A 501PHE A 506 | 1.76A | 19.78 | None | ||
![]() | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | HIS A 381MET B 87THR A 540ILE A 539SER A 501 | 1.61A | 18.12 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | HIS A 381MET B 87THR A 540ILE A 539SER A 501 | 1.62A | 18.12 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | HIS C1030MET C1011LEU C1016TRP C 868SER C 861 | 1.75A | 15.66 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 5 | ASN C 896THR C 894GLN C1088PHE C1091 | 1.65A | 15.56 | None | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6nb7 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | SER C 740GLN C 744PHE C 741 | 1.48A | 15.66 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6nb7 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | ASN C 783MET C 884PHE C 909 | 1.15A | 15.66 | NAG C1328 (-1.8A)NoneNone | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6nur | NSP12NSP8 (SARSr-CoV) | 5 / 12 | MET B 87THR A 540ILE A 539SER A 501PHE A 506 | 1.74A | 20.34 | None | ||
![]() | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6nur | NSP12NSP8 (SARSr-CoV) | 5 / 12 | MET B 87THR A 540ILE A 539SER A 501PHE A 506 | 1.67A | 19.78 | None | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6nur | NSP12NSP7NSP8 (SARSr-CoV) | 3 / 3 | MET D 94ASN A 414GLN C 19 | 1.12A | 20.34 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6nur | NSP12NSP7 (SARSr-CoV) | 3 / 3 | ASP C 38LEU C 41GLN A 444 | 1.33A | 12.12 | None | ||
![]() | 1XMU_B_ROFB102_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6nus | NSP12NSP8 (SARSr-CoV) | 5 / 12 | HIS A 381MET B 87ILE A 539PHE A 504SER A 501 | 1.66A | 17.68 | None | ||
![]() | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6nus | NSP12NSP8 (SARSr-CoV) | 5 / 12 | HIS A 381MET B 87THR A 540ILE A 539SER A 501 | 1.51A | 18.74 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6nus | NSP12NSP8 (SARSr-CoV) | 5 / 12 | HIS A 381MET B 87THR A 540ILE A 539SER A 501 | 1.52A | 18.31 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6nus | NSP12NSP8 (SARSr-CoV) | 5 / 12 | HIS A 381MET B 87THR A 540ILE A 539SER A 501 | 1.49A | 18.74 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN B 801MET B 902PHE B 927 | 1.00A | 15.56 | NAG B1309 (-1.8A)NoneNone | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | TYR B 279ASP B 40THR B 284ILE B 285PHE A 562 | 1.73A | 14.52 | None | ||
![]() | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | TYR B 279ASP B 40THR B 284ILE B 285PHE A 562 | 1.75A | 14.52 | None | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | SER C 803GLN C 804PHE C 817 | 0.94A | 15.56 | NAG C1307 ( 4.8A)NoneNone | ||
![]() | 3G4L_B_ROFB902_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | TYR B 279ASP B 40THR B 284ILE B 285PHE A 562 | 1.76A | 15.56 | None | ||
![]() | 1XMU_A_ROFA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6vw1 | ACE2 (Homosapiens) | 4 / 5 | ASN A 49THR A 52MET A 332GLN A 340 | 1.65A | 20.00 | NoneNoneNoneNAG A 710 (-3.6A) | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6vw1 | ACE2 (Homosapiens) | 4 / 5 | ASN A 49THR A 52MET A 332GLN A 340 | 1.66A | 20.00 | NoneNoneNoneNAG A 710 (-3.6A) | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN C1119MET A 900PHE C1095 | 1.79A | 15.41 | None | ||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | TYR C 279ASP C 40THR C 284ILE C 285PHE B 562 | 1.70A | 14.41 | None | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | SER A 803GLN A 804PHE A 817 | 1.24A | 15.41 | NAG A1314 (-3.4A)NAG A1314 (-3.8A)None | ||
![]() | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | TYR C 279ASP C 40THR C 284ILE C 285PHE B 562 | 1.72A | 14.41 | None | ||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN A 801MET A 902PHE A 927 | 1.10A | 15.41 | NAG A1314 (-1.9A)NoneNone | ||
![]() | 3G4L_B_ROFB902_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | TYR C 279ASP C 40THR C 284ILE C 285PHE B 562 | 1.74A | 15.41 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w4h | NSP10 (SARS-CoV-2) | 3 / 3 | ASP B4344LEU B4345GLN B4351 | 0.92A | 14.92 | None | ||
![]() | 1XMU_B_ROFB102_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6w4h | NSP16 (SARS-CoV-2) | 5 / 12 | TYR A6979HIS A7023TRP A6988PHE A6948SER A6927 | 1.69A | 24.12 | NoneNoneNoneACT A7104 (-4.7A)None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w4h | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ASP A6904PRO B4312THR B4309ILE B4308GLN B4351 | 1.48A | 22.00 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ASP A6904PRO B4312THR B4309ILE B4308GLN B4351 | 1.49A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w61 | NSP10 (SARS-CoV-2) | 3 / 3 | ASP B4344LEU B4345GLN B4351 | 0.89A | None | |||
![]() | 1XMU_B_ROFB102_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A6979HIS A7023TRP A6988PHE A6948SER A6927 | 1.66A | NoneNoneNoneEDO A7102 (-4.8A)None | |||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.73A | 21.84 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ASP C6904PRO D4312THR D4309ILE D4308GLN D4351 | 1.48A | 18.66 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ASP A6904PRO B4312THR B4309ILE B4308GLN B4351 | 1.47A | 18.66 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w75 | NSP10 (SARS-CoV-2) | 3 / 3 | ASP B4344LEU B4345GLN B4351 | 1.15A | 14.92 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASP A 179LEU A 178GLN A 133 | 1.68A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASP A 179LEU A 178GLN A 237 | 1.35A | None | |||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASN C 128MET C 169PHE C 127 | 1.75A | 20.96 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASP B 179LEU B 178GLN B 133 | 1.67A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASP B 179LEU B 178GLN B 237 | 1.59A | None | |||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU B 178PRO B 240ILE B 123PHE B 304MET B 244 | 1.80A | 20.37 | None | ||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | TYR F 333ILE E 320PHE F 286SER E 312PHE E 314 | 1.51A | 12.91 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP F 288LEU F 291GLN F 303 | 1.61A | None | |||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | TYR E 333ILE F 320PHE E 286SER F 312PHE F 314 | 1.60A | 12.91 | None | ||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | TYR B 333ILE A 320PHE B 286SER A 312PHE A 314 | 1.56A | 12.91 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP B 288LEU B 291GLN B 303 | 1.57A | None | |||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | TYR D 333ILE C 320PHE D 286SER C 312PHE C 314 | 1.57A | 12.91 | None | ||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | TYR C 333ILE D 320PHE C 286SER D 312PHE D 314 | 1.56A | 12.91 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP C 288LEU C 291GLN C 303 | 1.62A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP A 288LEU A 291GLN A 303 | 1.62A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP D 288LEU D 291GLN D 303 | 1.61A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP E 288LEU E 291GLN E 303 | 1.58A | None | |||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | TYR A 333ILE B 320PHE A 286SER B 312PHE B 314 | 1.55A | 12.91 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ASP A6904PRO B4312THR B4309ILE B4308GLN B4351 | 1.46A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wjt | NSP10 (SARS-CoV-2) | 3 / 3 | ASP D4344LEU D4345GLN D4351 | 1.20A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wjt | NSP10 (SARS-CoV-2) | 3 / 3 | ASP B4344LEU B4345GLN B4351 | 1.20A | None | |||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ASP C6904PRO D4312THR D4309ILE D4308GLN D4351 | 1.48A | None | |||
![]() | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 63LEU A 64PRO A 168SER B 79PHE A 171 | 1.67A | 14.59 | NoneNoneNone ZN B 202 (-3.2A)None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ASP C6904PRO D4312THR D4309ILE D4308GLN D4351 | 1.47A | None | |||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | ASP A6904PRO B4312THR B4309ILE B4308GLN B4351 | 1.48A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wkq | NSP10 (SARS-CoV-2) | 3 / 3 | ASP D4344LEU D4345GLN D4351 | 1.21A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wkq | NSP10 (SARS-CoV-2) | 3 / 3 | ASP B4344LEU B4345GLN B4351 | 1.16A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASP A 297LEU A 252GLN A 202 | 1.75A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 3 / 3 | ASP B 297LEU B 252GLN B 202 | 1.63A | None | |||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.77A | 21.84 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | ASP A6904PRO B4312THR B4309ILE B4308GLN B4351 | 1.47A | NoneNoneSO4 B4404 (-3.8A)NoneNone | |||
![]() | 1XMU_B_ROFB102_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | TYR A6979HIS A7023TRP A6988PHE A6948SER A6927 | 1.69A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | ASP A 216LEU A 282GLN A 299 | 1.73A | None | |||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.75A | 21.84 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | ASP A 179LEU A 178GLN A 237 | 1.60A | None | |||
![]() | 3G4L_D_ROFD904_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | ASN A 128MET A 169PHE A 127 | 1.69A | 22.44 | PO4 A 504 (-3.7A)NoneNone | ||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6xez | NSP12 (SARS-CoV-2) | 3 / 3 | SER A 78GLN A 81PHE A 77 | 1.33A | 17.78 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 5 | ASN B 151THR B 111GLN B 127PHE B 8 | 1.70A | 21.84 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.76A | 18.38 | NoneNoneDMS A 403 (-3.4A)DMS A 403 (-3.8A) | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 3 / 3 | ASP C 38LEU C 41GLN A 19 | 0.95A | None | |||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 3 / 3 | ASP A 38LEU A 41GLN C 19 | 1.22A | None | |||
![]() | 1XOQ_A_ROFA502_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6yi3 | NUCLEOPROTEIN (SARS-CoV-2) | 3 / 3 | ASN A 37TRP A 12GLN A 43 | 1.53A | 15.47 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | ASP A 216LEU A 282GLN A 299 | 1.73A | None | |||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.79A | 22.03 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.76A | 22.03 | None CL A 406 ( 3.6A) CL A 406 (-4.1A)None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.77A | 21.84 | None | ||
![]() | 3G4L_A_ROFA901_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASP A 304LEU A 308GLN A 292 | 1.79A | None | |||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 7btf | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | HIS A 381MET B 87LEU A 372ILE A 539SER A 501 | 1.59A | None | |||
![]() | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | SER A 78GLN A 81PHE A 77 | 1.32A | 18.12 | None | ||
![]() | 1XMU_B_ROFB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 5 | ASN A 151THR A 111GLN A 127PHE A 8 | 1.76A | 21.84 | NoneNoneDMS A 406 (-3.3A)DMS A 406 (-3.7A) | ||
![]() | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 7bv1 | NSP12NSP7NSP8 (SARS-CoV-2) | 3 / 3 | MET D 94ASN A 414GLN C 19 | 1.43A | 20.57 | None | ||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 7bv1 | NSP8 (SARS-CoV-2) | 5 / 12 | ASP D 163THR D 187ILE D 185MET D 129GLN D 158 | 1.79A | None | |||
![]() | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | HIS A 381MET B 87LEU A 372THR A 540SER A 501 | 1.53A | NoneNoneNoneNone U T 9 ( 2.7A) | |||
![]() | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | HIS A 381MET B 87LEU A 372THR A 540SER A 501 | 1.49A | 18.03 | NoneNoneNoneNone U T 9 ( 2.7A) |